News

ICYMI, this week we had stories about characteristics of generalized pustular psoriasis, the psychosocial impact of vitiligo, new laser treatments for acne, and more.

In this week’s Pointers with Dr Portela, the 208SkinDoc, asks consumers about the basics of skin health and skin care.

Recent, continued research in genetic profiling has made personalized medicine more of a reality and brought the concept a step closer to potential regular use in general dermatology practice.

Happy Thanksgiving from the Dermatology Times® Editorial Advisory Board and editors!

Using pooled 52-week results from TRuE-AD1 and TRuE-AD2, investigators examined how the topical JAK1/JAK 2 inhibitor affects patient feelings of skin pain, discomfort, anxiety, and depression.

Dermoscopy is a valuable tool in differentiating regular pigmented lesions from dangerous skin cancers. At SDPA 2022, Orit Markowitz, MD, summarizes skin of color dermoscopy.

After reporting initial data earlier this year, investigators presented a fuller analysis in a poster at the 2022 SDPA Annual Fall Dermatology Conference.

The greatest improvements in quality of life measures were seen in the 300 mg tralokinumab group.

Click here to see a preview of what to expect this week.

ICYMI, this week we had stories about IL-17 inhibitor durability in plaque psoriasis, benzene contamination in dry shampoo products, an interview with Muneeb Shah, DO, and more.

November kicks off National Healthy Skin Month, presenting an opportunity to learn new habits for healthier skin.

Valisure, an independent laboratory, recently sent a Citizen's Petition to the FDA regarding high levels of benzene found in dry shampoo products.

ICYMI, this week we had stories about blastic plasmacytoid dendritic cell neoplasm, epidermolysis bullosa, an interview with Seth Matarasso, MD, and more.

Christopher Bunick, MD, PhD, shares his thoughts on the latest report of concerning levels of benzene, a human carcinogen, found in dry shampoos recalled last month.

ICYMI, this week we had stories about product recalls due to benzene, advanced wound care in the US, a Fall Clinical recap, and more.

MGMA survey quantifies rising costs, revenues, patient encounters, and more.

Catch up on coverage from the 2022 Fall Clinical Dermatology Conference.

State of Skin Sensitivity Report raises awareness of the causes of skin sensitivity and its effect on the mind.

In this week’s Pointers with Dr Portela, the 208SkinDoc reviews the social media phenomenon of "dermarolling."

Christopher Bunick, MD, PhD, discusses the 5th personal care product category recall, dry shampoos, due to heightened levels of benzene.

A real-world, cohort study finds popular skin rash drugs also boost moods.

Dry shampoo products were found to contain elevated levels of a cancer-causing chemical.

Raj Chovatiya, MD, PhD, assistant professor of dermatology and Medical Director, Center for Eczema and Itch and Medical Director, Clinical Trials Unit at the Northwestern University Feinberg School of Medicine in Chicago, Illinois, shares highlights from his upcoming presentations at Fall Clinical in Las Vegas, Nevada, October 20-23, 2022.

Acute exposure can elevate biomarkers associated with contact dermatitis and psoriasis.

Administration pushes for vaccines and boosters for the fall.

Patients with DM may find relief from a psoriasis drug in addition to their regular therapies.

Click to see a preview of what to expect this week.

ICYMI, this week we had stories about the American Society for Dermatologic Surgery Meeting, pediatric nail disorders, generalized pustular psoriasis treatment, and more.

Lack of providers, stigma are barriers to seeking needed care, but meaningful conversations can help.

A new study shows the AD drug does not interfere with vaccinations or increase severity.